Faramarzi, Mohammad Ali
Tehran University of Medical Sciences,
Iran, Islamic Republic of
2025 Rank: 89,226
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Biotechnology
Rank in SubField 1: 313 out of 112,089 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 89,226 | 86,547 |
| Total Cites | 1,383 | 1,657 |
| H-index | 14 | 16 |
| Hm-index | 8 | 9 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 53 | 53 |
| Number of Single+First+Last Authored Papers | 134 | 134 |
| Total Cites to Single+First+Last Authored Papers | 482 | 546 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,152 | 1,233 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.34 |
| Self-Citation Percentage |
16.54%
|
|
Faramarzi, Mohammad Ali
Tehran University of Medical Sciences,
Iran, Islamic Republic of
2024 Rank: 80,085
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Biotechnology
Rank in SubField 1: 259 out of 105,998 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 80,085 | 81,654 |
| Total Cites | 1,312 | 1,547 |
| H-index | 14 | 14 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 78 | 78 |
| Number of Single+First+Last Authored Papers | 129 | 129 |
| Total Cites to Single+First+Last Authored Papers | 468 | 530 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,046 | 1,118 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.38 |
| Self-Citation Percentage |
15.19%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Biotechnology
Rank in SubField 1: 363 out of 99,369 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 103,050 | 99,489 |
| Total Cites | 1,137 | 1,398 |
| H-index | 14 | 15 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 41 | 42 |
| Number of Single+First+Last Authored Papers | 125 | 125 |
| Total Cites to Single+First+Last Authored Papers | 455 | 528 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 974 | 1,056 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.32 |
| Self-Citation Percentage |
18.67%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Biotechnology
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 297 out of 56,174 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 79,028 | 80,554 |
| Total Cites | 1,006 | 1,189 |
| H-index | 15 | 16 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 77 | 77 |
| Number of Single+First+Last Authored Papers | 113 | 113 |
| Total Cites to Single+First+Last Authored Papers | 448 | 477 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 865 | 937 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.27 |
| Self-Citation Percentage |
15.39%
|
|
Faramarzi, Mohammad Ali
Tehran University of Medical Sciences,
Iran, Islamic Republic of
2021 Rank: 84,992
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Biotechnology
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 325 out of 52,513 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 84,992 | 80,938 |
| Total Cites | 1,375 | 1,665 |
| H-index | 19 | 22 |
| Hm-index | 9 | 10 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 112 | 115 |
| Number of Single+First+Last Authored Papers | 104 | 104 |
| Total Cites to Single+First+Last Authored Papers | 639 | 708 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,184 | 1,292 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.29 |
| Self-Citation Percentage |
17.42%
|
|
Faramarzi, Mohammad Ali
Tehran University of Medical Sciences,
Iran, Islamic Republic of
2020 Rank: 96,602
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Biotechnology
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 394 out of 50,343 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 96,602 | 98,601 |
| Total Cites | 926 | 1,087 |
| H-index | 13 | 15 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 69 | 71 |
| Number of Single+First+Last Authored Papers | 95 | 95 |
| Total Cites to Single+First+Last Authored Papers | 435 | 489 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 792 | 864 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.26 |
| Self-Citation Percentage |
14.81%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.